- Report
- July 2026
- 198 Pages
Global
From €7114EUR$7,990USD£6,113GBP
- Report
- July 2026
- 200 Pages
Global
From €7114EUR$7,990USD£6,113GBP
- Report
- July 2026
- 174 Pages
Global
From €7114EUR$7,990USD£6,113GBP
- Report
- July 2026
- 200 Pages
Global
From €7114EUR$7,990USD£6,113GBP
- Report
- July 2026
- 232 Pages
Global
From €7114EUR$7,990USD£6,113GBP
- Report
- April 2026
- 280 Pages
Global
From €4452EUR$5,000USD£3,825GBP
- Report
- January 2026
- 250 Pages
Global
From €3116EUR$3,500USD£2,678GBP
- Report
- January 2026
- 450 Pages
Global
From €4452EUR$5,000USD£3,825GBP
- Report
- November 2025
- 200 Pages
Global
From €7078EUR$7,950USD£6,082GBP
- Report
- November 2025
- 200 Pages
Global
From €7078EUR$7,950USD£6,082GBP
- Clinical Trials
- May 2026
- 60 Pages
Global
From €1113EUR$1,250USD£956GBP
- Clinical Trials
- May 2026
- 180 Pages
Global
From €1781EUR$2,000USD£1,530GBP
- Report
- May 2026
- 30 Pages
Global
From €2448EUR$2,750USD£2,104GBP
- Clinical Trials
- April 2026
- 180 Pages
Global
From €1781EUR$2,000USD£1,530GBP
- Report
- April 2026
- 30 Pages
Global
From €2448EUR$2,750USD£2,104GBP
- Drug Pipelines
- March 2026
- 150 Pages
Global
From €3339EUR$3,750USD£2,869GBP
- Report
- March 2026
- 30 Pages
Global
From €2448EUR$2,750USD£2,104GBP
- Report
- January 2026
- 500 Pages
Global
From €4452EUR$5,000USD£3,825GBP
- Report
- January 2026
- 180 Pages
Global
From €2226EUR$2,500USD£1,913GBP
- Report
- January 2026
- 100 Pages
Global
From €2226EUR$2,500USD£1,913GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more